According to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
Bankruptcy, Biotech, Bioterrorism, Births, Business, Carcinogens, China, CRISPR, Fraud, Gene Editing, Genes, Government, HIV, Medicare, N-nitrosodimethylamine (NDMA), Opioids, Pharma, PhRMA, Restructuring, Spinal Muscular Atrophy (SMA), StudiesFor Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
PhRMA CEO Stephen Ubl said House Speaker Nancy Pelosi’s plan would be “devastating” to the industry.
Hospitals are continuing to charge, on average, five times their cost for medicines, according to a study by The Moran Company commissioned by PhRMA.
Canada’s main pharmaceutical lobby group urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents seen by Reuters.
Main pharmaceutical industry lobbying group PhRMA and some drugmakers met with President Donald Trump to voice opposition to a bipartisan U.S. Senate bill that aims to lower prescription drug prices.
The Trump administration will require drugmakers to disclose the list price of prescription drugs in DTC TV advertisements, part of the government’s efforts to lower costs for U.S. consumers.
Healthcare Agency Roundtable 2018
Amazon, AR/VR, Artificial Intelligence, Blockchain, December 2018, Digital Health, DTC, Gender diversity, Gender Parity, Google, Healthcare Agency Roundtable, Healthcare Communications Agencies, Healthcare Communications Networks, Healthcare/Medicare/Medicaid, Issue Archives, Mixed Reality (MR), PhRMA, Predictive Analytics, Special Reports, Therapeutics, Trump AdministrationLeadership representing the 2018 Manny Award agency and network winners and finalists share their views on various healthcare industry trends and developments.
In a move that seems designed to head off potential legislative action, PhRMA announced that member companies would be taking a new approach to DTC television advertising.
Whatever comes out of Congress on the “repeal and replace” of the Affordable Care Act (ACA or Obamacare) matters because it will affect the bottom line of the life sciences industry as well as all of its industry partners.